Search results
Results from the WOW.Com Content Network
In 2009, Ethicon acquired breast implant maker Mentor, [8] [9] and in 2010 it acquired ear, nose and throat technology company Acclarent. [10] In 2016, Ethicon acquired NeuWave Medical. [11] In 2013, J&J merged Ethicon Endo-Surgery back into Ethicon. [6] As of Septemberr 10, 1024, Ethicon began operating under the name Johnson & Johnson MedTech ...
3 Average 61% reduction in tip travel during firing when compared to Ethicon Endo-Surgery Echelon Flex™* in indicated media, p<0.0005 (Seils D., Tantawy T., Peterson D., Final Report on Results ...
In 2003, Ethicon launched Vicryl Plus Antibacterial Sutures. The products prevent post-surgery infection within stitches. In 2006, Johnson & Johnson acquired Pfizer's consumer healthcare business and merged it with its consumer healthcare business group. The acquisition added brands like Listerine, Bengay, and Neosporin to the company's ...
Johnson & Johnson -owned Ethicon announced in a press release Monday that the FDA has granted regulatory approval for its Enseal G2 tissue sealer. Ethicon's newest approved device is the first ...
He is also the founder and Chairman of Novacept (women's health), sold to Cytyc Corporation, [18] Sound ID (hearing science), [19] Pulmonx (interventional pulmonology and emphysema treatment), [20] and was Chairman of Surgrx (electrosurgical instrumentation), which was sold to Ethicon Endo-Surgery, [21] a division of Johnson & Johnson, [22] in ...
Language links are at the top of the page. Search. Search
move to sidebar hide. From Wikipedia, the free encyclopedia
The Center for Tissue Regeneration and Engineering at Dayton (TREND) is a research center which focuses on tissue regeneration and is partnered with the National Institutes of Health, the National Science Foundation, Air Force Research Laboratory, and Ethicon Endo-Surgery. The center is located in Dayton, Ohio.